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Abstract The finding that hydralazine (HYD) affects col-
lagen metabolism led us to investigate the mechanism of its
action on collagen biosynthesis, prolidase expression and
activity, expression of α2β1 integrin, insulin-like growth
factor-I receptor (IGF-IR), focal adhesion kinase (FAK),
mitogen-activated protein (MAP) kinases (ERK1, ERK2),
and transcription factors hypoxia-inducible factor-1α (HIF-
1α) and nuclear factor-κB p65 (NF-κB p65) in human
dermal fibroblasts. Confluent fibroblasts were treated with
micromolar concentrations (50–500 μM) of HYD for 24 h.
HYD had no influence on cell viability. It was found that
HYD-dependent increase in collagen biosynthesis was ac-
companied by a parallel increase in prolidase activity and
expression, HIF-1α expression, and decrease in DNA bio-
synthesis, compared to untreated cells. Since collagen bio-
synthesis and prolidase activity are regulated by a signal
induced by activated α2β1 integrin receptor as well as IGF-
IR, the expression of these receptors was measured by
Western immunoblot analysis. The exposure of the cells to
HYD contributed to the increase in IGF-IR expression with-
out any effect on α2β1 integrin receptor and FAK expres-
sions. It was accompanied by a decrease in expression of
MAP kinases and NF-κB p65, the known inhibitor of col-
lagen gene expression. The data suggest that the HYD-
dependent increase of collagen biosynthesis in cultured hu-
man skin fibroblasts results from activation of IGF-IR ex-
pression and prolidase activity and downregulation of
NF-κB p65.
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Introduction
Hydralazine (HYD, 1-hydrazinophthalazine), a well-known
medicine for hypertension, causes metabolic changes in the
connective tissue, including increase in tissue collagen con-
tent, collagenolytic activity, and lysosomal exoglycosidases
activity in rat tissues (Weglarz et al. 1990; Meilman et al.
1965). An increased activity of these enzymes suggest that
HYD-induced connective tissue damage, probably is an
inflammatory type (Olczyk et al. 1988). Fibroblasts treated
with HYD synthesized procollagen which was severely
deficient in hydroxyproline and hydroxylysine, indicating
an inhibition of prolyl and lysyl hydroxylase reactions in the
cells. Assays of prolyl and lysyl hydroxylase activities,
however, revealed markedly increased levels in HYD-
treated cells (Murad et al. 1985).
Collagen biosynthesis in human dermal fibroblasts may
depend on the activity of prolidase (Surazynski et al. 2008a).
Prolidase [E.C.3.4.13.9] is a cytosolic enzyme which cata-
lyzes hydrolysis of imidodipeptides (mainly derived from
collagen degradation), releasing proline, which is used for
collagen resynthesis (Jackson and Heininger 1973; Jackson
et al. 1975). Prolidase activity is stimulated through a signal
mediated by collagen-β1 integrin receptor interaction (Palka
and Phang 1997). More interestingly, prolidase has been
found to be involved in the regulation of transcription factor
HIF-1α. The potential mechanism of this process was dem-
onstrated in breast cancer cells (Surazynski et al. 2008b).
The activity of HIF-1α is controlled at the level of its
degradation. The hydroxylation of specific proline residue
in the oxygen-dependent degradation (ODD) domain of
HIF-1α targets HIF-1α for ubiquitination and proteosomal
degradation via Von Hippel–Lindau (VHL) tumor suppres-
sor protein (Jaakkola et al. 2001). Proline and hydroxypro-
line, as products of prolidase function, inhibit the
degradation of HIF-1α presumably by interference between
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VHL and the hydroxyproline in ODD. As a result of over-
expression of prolidase, HIF-1α is not degraded and func-
tion as transcription factor for the activation of some genes,
as for instance vascular endothelial growth factor (VEGF)
(Surazynski et al. 2008b). Therefore, stimulation of proli-
dase activity may prevent HIF-1α degradation and facilitate
its role as an inducer of angiogenesis. It is known that
hydralazine activates the HIF-1α pathway through the inhi-
bition of prolyl hydroxylase domain activity and initiates a
pro-angiogenic phenotype (Knowles et al. 2004).
Another factor that strongly stimulates collagen biosyn-
thesis is insulin-like growth factor (IGF)-I, acting predomi-
nantly through the IGF-I receptor (Goldstein et al. 1989).
The effects of IGF-I include the induction of collagen gene
expression (Tanaka et al. 2002), upregulation of prolidase
activity (Miltyk et al. 1998), stimulation of mitotic division,
and prevention of apoptosis (Baserga 2005). Some of these
activities are regulated through NF-κB, the known inhibitor
of collagen gene expression (Kouba et al. 1999).
In this study, we examined the effect of HYD on collagen
biosynthesis and prolidase activity and expression, DNA
biosynthesis and cell viability, expression of α2β1 integrin,
IGF-I receptor, FAK, MAP kinases (ERK1, ERK2), and the
transcription factors—NF-κB p65 and HIF-1α—in human
dermal fibroblasts.
Materials and methods
Alkaline phosphatase-labeled anti-mouse IgG, anti-rabbit
IgG, and anti-goat IgG antibodies, aprotinin, bacterial col-
lagenase, captopril, Fast BCIP/NBT reagent, hydralazine
hydrochloride, L-glycyl-proline, L-proline, leupeptin, mono-
clonal (mouse) anti-IGF-IR antibody, monoclonal (mouse)
anti-phosphorylated MAPK ERK1/2 antibodies, monoclo-
nal (mouse) anti-phosphotyrosine antibody, 3-(4,5-dime-
thylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
Nonidet P-40, and phenylmethylsulfonyl fluoride were pro-
vided by Sigma Corp., USA., as were most other chemicals
and buffers used. Dulbecco’s minimal essential medium and
fetal bovine serum (FBS) used in cell culture were products
of Gibco, USA. Glutamine, penicillin, and streptomycin
were obtained from Quality Biologicals Inc., USA.
Nitrocellulose membrane (0.2 μm), sodium dodecylsulphate
(SDS), polyacrylamide, molecular weight standards, and
Coomassie Brilliant Blue R-250 were received from Bio-
Rad Laboratories, USA. L-5[3H] proline (28 Ci/mmol) was
purchased from Amersham, UK. [3H] Thymidine
(6.7 Ci/mmol) was obtained from NEN (USA).
Monoclonal (mouse) anti-β1, polyclonal (rabbit) anti-α2-
integrin, polyclonal (rabbit) NF-κB p65, polyclonal (goat)
anti-β-actin, and monoclonal (rabbit) anti-FAK antibodies
were the products of Santa Cruz Biotechnology Inc., USA.
Monoclonal (mouse) anti-hypoxia-inducible factor (HIF-
1α) antibody was obtained from Becton, Dickinson Co.,
USA. Polyclonal anti-human prolidase antibody was donat-
ed by Dr. James Phang (NCI-Frederick Cancer Research and
Development Center, Frederick, MD, USA).
All studies were performed on normal human skin fibro-
blasts (CRL-1474) that were purchased from American
Type Culture Collection, Manassas, VA, USA.
Collagen production
Incorporation of radioactive precursor into proteins was
measured after labeling of confluent cells in growth medi-
um, with HYD for the last 24 h with 5[3H] proline
(5 μCi/ml, 28 Ci/mM) as described previously (Oyamada
et al. 1990). Incorporation of tracer into collagen was deter-
mined by digesting proteins with purified Clostridium his-
tolyticum collagenase, according to the method of
Peterkofsky et al. (1982). Results are shown as combined
values for cell plus medium fractions.
Determination of prolidase activity and proline
The activity of prolidase was determined according to the
method of Myara et al. (1982). Proline was measured by
Chinard’s reagent (Chinard 1952). Protein concentration
was measured by the method of Lowry et al. (1951).
Enzyme activity was reported as nanomoles of proline re-
leased from synthetic substrate, during 1 minmg−1 of super-
natant protein of cell homogenate.
Immunoprecipitation
The cells at about 90 % of confluence were rinsed with
phosphate-buffered saline (PBS), scraped out of the wells,
and centrifuged at 1,000×g for 3 min. Then the cells (from
six wells) were solubilized with lysis buffer containing
10 mM Tris–HCl, pH7.4, 250 mM NaCl, 0.5 % Nonidet
P-40, 1 mM EDTA, 1 μg/ml leupeptin, 1 μg/ml aprotinin,
and 1 mM phenylmethylsulfonyl fluoride, at 4 °C for
10 min. The insoluble material was removed by centrifuga-
tion at 10,000×g for 5 min at 4 °C. The supernatant con-
taining 100 μg of protein was added to 100 μg of Protein A-
Sepharose that has been linked to the polyclonal anti-human
prolidase antibody in the following manner: Protein A-
Sepharose was washed three times with lysis buffer and
100 μl of suspension containing about 100 μg of beads
was incubated for 1 h at 4 °C with either 20 μl of anti-
prolidase antibody. Then, the conjugate was incubated for
1 h at 4 °C with shaking. Immunoprecipitate was washed
four times with lysis buffer. Proteins were released from the
beads by boiling in SDS sample buffer and loaded into a
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10 % SDS–polyacrylamide gel (PAGE). The immunopreci-
pitates were analyzed by Western immunoblot.
SDS–PAGE and Western blot analysis
Slab SDS/PAGE was used, according to the method of
Laemmli (1970), by using 10 % SDS-polyacrylamide gel.
Western blot analysis was performed as described previous-
ly (Miltyk et al. 1998).
DNA biosynthesis assay
To examine the effect of hydralazine on fibroblast prolifer-
ation, the cells were plated in 24-well tissue culture dishes at
1×105 cells/well with 1 ml of growth medium. After 48 h
(1.6±0.1×105 cells/well), the plates were incubated with
various concentrations of HYD and 0.5 μCi of [3H] thymi-
dine for 24 h at 37 °C. Cells were rinsed three times with
PBS, solubilized with 1 ml of 0.1 M sodium hydroxide
containing 1 % SDS, scintillation liquid (9 ml) was added,
and radioactivity incorporated into DNAwas measured in a
scintillation counter.
Cell viability assay
The assay was performed according to the method of
Carmichael et al. (1987) using 3-(4,5-di-methylthiazole-2-
yl)-2,5-diphenyltetrazolium bromide (MTT). The cells were
cultured for 24 h with various concentrations of HYD in six-
well plates, washed three times with PBS and then incubated
for 4 h in 1 ml of MTT solution (0.5 mg/ml of PBS) at
37 °C. The medium was removed, and 1 ml of 0.1 mol/l HCl
in absolute isopropanol was added to attached cells.
Absorbance of converted dye in living cells was measured
at a wavelength of 570 nm. Cell viability in the presence of
BA was calculated as a percent of control cells.
Statistical analysis
In all experiments, the mean values for three independent
experiments done in duplicates±standard deviation (SD)
were calculated. The results were submitted to statistical
analysis using one-way ANOVA followed by Tukey test,
accepting P≤0.05 as significant versus control.
Results
Studies were performed on confluent fibroblasts, since
collagen synthesis, prolidase activity, as well as IGF-IR
expression depend on cell density (Myara et al. 1985;
Makela et al. 1990).
Collagen biosynthesis was measured in confluent human
dermal fibroblasts that have been treated with 50, 100, 250,
and 500 μM of HYD or captopril (CAP). As can be seen on
Fig. 1a, 24 h of incubation of confluent fibroblasts in the
medium containing 10 % FBS and different concentrations
of HYD contributed to the increase in collagen biosynthesis
in a dose-dependent manner. At 500 μM, HYD induced a
twofold increase in collagen biosynthesis compared to
control.
The effect was not achieved in the cells treated with CAP,
and it was not related to stimulation of DNA synthesis
(Fig. 2a).
To explain the mechanism of this process, we considered
prolidase as a target enzyme. Increase in collagen biosyn-
thesis in HYD-treated cells was correlated to the increase in
prolidase activity (Fig. 1b). It was accompanied by an in-
crease in prolidase expression (Fig. 1c) and decrease in
prolidase phosphorylation (Fig. 1d). Moreover, HYD-
treated cells contained more free proline (about 15 μM)
compared to control cells (about 11 μM) as detected by
Chinard assay (data not shown).
Since prolidase has been found to be involved in the
regulation of transcription factor HIF-1α, we determined
its expression in fibroblasts treated with different concen-
trations of HYD for 24 h. A distinct increase in the expres-
sion of HIF-1α was observed compared to control cells
(Fig. 1e).
The increase in collagen biosynthesis in HYD-treated
fibroblasts was unrelated to cell proliferation. In fact, it
was correlated to the slight decrease in DNA biosynthesis
(Fig. 2a) and MAP kinases, ERK1/2 (Fig. 3e), compared to
control. Moreover, cell viability was measured by the meth-
od of Carmichael et al. (1987) using tetrazolinum salt. The
viability of cells incubated for 24 h with indicated concen-
trations of HYD is presented on Fig. 2b. HYD did not
influence the viability of the cells. The stability of cells in
respect to the rate of proliferation and cell viability may
result from experimental model of confluent cells.
Collagen biosynthesis and prolidase activity were previ-
ously shown to be regulated due to the signal induced by the
activated α2β1 integrin receptor (Palka and Phang 1997) as
well as insulin-like growth factor-I receptor (Goldstein et al.
1989; Miltyk et al. 1998). Therefore, the expression of α2β1
integrin receptor (receptor for type I collagen) and IGF-IR
were measured by Western immunoblot analysis. As can be
seen in Fig. 3a, b, 24 h of treatment of the fibroblasts with
HYD had very small effect on the expression of α2 and β1
integrin subunits. Similarly, very small differences were
observed in the expressions of FAK (Fig. 3c). However, as
shown on Fig. 3d, IGF-I receptor expression was increased
in HYD-treated cells compared to the control cells. This
suggests that the ability of HYD to induce increase of
collagen biosynthesis may depend on the transcriptional
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regulatory mechanism induced by signal mediated by IGF-I
receptor. On the other hand, we have found that, in HYD-
treated cells, there is decrease in the expression of NF-κB
p65, the known inhibitor of collagen gene expression
(Kouba et al. 1999) compared to control cells (Fig. 3f).
In view of this data, it seems that the increase of collagen
biosynthesis caused by HYD may be a consequence of
increase in IGF-I receptor signaling, prolidase activity and
decrease in expression of NF-κB p65.
Discussion
The finding that HYD causes changes in collagen metabo-
lism led us to investigate the mechanism of its action on
collagen biosynthesis in fibroblasts—the main collagen-
synthesizing cells (Makela et al. 1990). The drug induces
hypertrophy in the myocardium after infarction in rats (Leite
et al. 1995). Although several studies on animal models
have shown that HYD treatment reduces fibrosis in some
tissues, it cannot correspond to reduced collagen synthesis.
Upregulation of collagen synthesis may reflect interstitial
remodeling leading to increase or decrease of tissue collagen
content depending on the rate of collagen degradation. It
Fig. 1 Collagen biosynthesis (a) measured as 5[3H] proline incorpo-
ration into proteins susceptible to the action of bacterial collagenase
and prolidase activity (b) in confluent human skin fibroblasts incubated
for 24 h in the medium containing 10 % FBS and different concen-
trations of HYD or CAP. The results present the mean values from six
assays ± SD. The asterisk indicates P≤0.05. Western blot analysis for
prolidase (c), phosphorylated prolidase (d), hypoxia-inducible factor
(HIF-1α) (e), in control human skin fibroblasts (lane 1) and cultured in
the medium containing 50 μM of HYD (lane 2), 100 μM of HYD (lane
3), 250 μM of HYD (lane 4), and 500 μM of HYD (lane 5). The mean
values of six pooled cell homogenate extracts from six separate experi-
ments are presented. The intensity of the bands was quantified by
densitometric analysis. Densitometry was done with BioSpectrum
Imaging System and presented as arbitrary units. Twenty micrograms
of supernatant protein was run in each lane for prolidase and β-actin
Western blot analysis. 60 μg of supernatant protein was run in each
lane for HIF-1α Western blot analysis. The expression of β-actin
served as a control for protein loading (f)
Fig. 2 DNA synthesis (a) and viability (b) of confluent human skin
fibroblasts incubated for 24 h with different concentrations of hydral-
azine. The mean values±SD from three independent experiments done
in duplicates are presented. The asterisk indicates P≤0.05
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was supported by some studies showing HYD-dependent
increase in type III collagen content in myocardium. An
example is the paper of Tsotetsi et al. (2001). Conflicting
results were obtained by Murad et al. (1985), however, in
different experimental conditions, including prolonged time
of incubation.
It seems that experimental concentrations of HYD, used
in present study, are pharmacologically relevant. Maximal
dose of hydralazine may contribute to the micromolar
concentration in plasma. Several studies “in vitro” were
performed with higher hydralazine concentration (Liu-
Snyder et al. 2006). Hydralazine at 50 to 500 μmol/L rap-
idly induced HIF-1α protein in endothelial cells (HUVEC)
(Knowles et al. 2004).
Our studies suggest potential mechanism for HYD-
dependent effect on collagen biosynthesis. The specific-
ity of HYD on collagen biosynthesis was corroborated
by parallel experiments with CAP, another hypotensive
drug that, in presented experimental conditions, had no
effect on the process. It was confirmed in our previous
studies (Karna et al. 2010).
Since collagen is regulated by IGF-IR (Goldstein et al.
1989), we postulated that the effects of HYD on collagen
production may be related to alterations in intracellular
signaling pathway generated by IGF-IR. In fact the data
presented here show that HYD-induced collagen biosyn-
thesis is accompanied by an increase in the expression of
IGF-IR as well as prolidase activity. Previously, it has
been shown that prolidase is stimulated by IGF-I (Miltyk
et al. 1998). Moreover, prolidase is phosphoserine/threo-
nine protein. Increase in the enzyme phosphorylation con-
tributes to increase in the enzyme activity (Surazynski et
al. 2001, 2005). Although a relatively slight increase
(41 %) in prolidase activity in HYD-treated cells does
not correspond to the high enzyme protein expression
(threefold), it may be due to the low extent of prolidase
phosphorylation. Nevertheless, much more (about 36 %)
free proline content in HYD-treated cells was found com-
pared to that of the control cells, suggesting upregulation
of prolidase activity.
Prolidase catalyzes the final step in collagen degradation
which completes the recycling of proline for collagen re-
synthesis (Jackson and Heininger 1973; Yaron and Naider
1993). The best and most abundant substrate for prolidase is
glycyl-proline (Gly-Pro). Collagen represent polypeptide
containing the highest amount of imido bonds compared to
all known proteins. In α1 chains of type I collagen, Gly-Pro
occurs 25 times (Jackson et al. 1975). Therefore, HYD-
induced prolidase activity may represent one of the mecha-
nisms of collagen biosynthesis regulation. The functional
link between collagen and prolidase activity has been also
found in cultured human skin fibroblasts treated with anti-
inflammatory drugs (Miltyk et al. 1996), pyrroline-5-
carboxylate (Miltyk and Palka 2000), during experimental
aging of these cells (Palka et al. 1996), fibroblast chemo-
taxis (Palka et al. 1997), and cell surface integrin receptor
ligation (Palka and Phang 1997).
Prolidase plays an important role in HIF-1α signaling.
The mechanism of this process involves products of proli-
dase activity, proline, or hydroxyproline that prevent hy-
droxylation of specific proline residue in the ODD domain
of HIF-1α and prevent targeting HIF-1α for ubiquitination
Fig. 3 Western blot analysis for α2-integrin (a), β1-integrin (b) recep-
tor subunits, FAK (c), IGF-I receptor (d), ERK1/ERK2 (e), and NF-κB
p65 (f) in control human skin fibroblasts (lane 1) and cultured in the
medium containing 50 μM of HYD (lane 2), 100 μM of HYD (lane 3),
250 μM of HYD (lane 4), and 500 μM of HYD (lane 5). The mean
values of six pooled cell homogenate extracts from six separate experi-
ments are presented. The intensity of the bands was quantified by
densitometric analysis. Densitometry was done with BioSpectrum
Imaging System and presented as arbitrary units. The same amount
of supernatant protein (20 μg) was run in each lane. The expression of
β-actin served as a control for protein loading (g)
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and proteosomal degradation via Von Hippel–Lindau
(VHL) tumor suppressor protein (Jaakkola et al. 2001).
Therefore, proline and hydroxyproline may contribute to
activation of HIF-1α and activation of some pro-
neoplastic genes, as for instance VEGF (Surazynski et
al. 2008b). Therefore, stimulation of prolidase activity
(e.g., by HYD) may prevent HIF-1α degradation and
facilitate its role as an inducer of angiogenesis. The mech-
anism was proved in breast and colon cancer cell lines
(MCF-7, MDA-MB 231, and DLD-1), showing prolidase-
dependent differences in HIF-1α activation (Surazynski et
al. 2008b; Karna et al. 2012). Although in present studies
we found increased proline concentration in hydralazine-
treated cells, it is uncertain whether it is a product of
degradation of proline-containing dipeptides or proline
biosynthesis. It cannot be excluded as another possibility.
HYD has been shown to inhibit prolyl hydroxylase activ-
ity in cell-free assay and prevented hydroxylation (and
subsequent degradation) of HIF-1α in cultured cells
(Knowles et al. 2004; Bhatnagar et al. 1972). This process
prevents also posttranslational modification of collagen
prolyl residues essential for the formation of stable colla-
gen fibers (Murad et al. 1985).
Nevertheless, the constellation of changes induced by
HYD, found in this study suggest important role of proli-
dase in upregulation of collagen synthesis. It supports our
previous studies on butyrate on the regulation of collagen
biosynthesis (Karna et al. 2006). Several other studies sug-
gest that prolidase-dependent regulation of collagen biosyn-
thesis may take place at the transcriptional level. The
transfection of colorectal cancer cells with prolidase vector
inhibited NF-κB expression (Surazynski et al. 2008a), a
well-recognized inhibitor of expression of α1 and α2 sub-
units of type I collagen (Kouba et al. 1999; Rippe et al.
1999; Miltyk et al. 2007). Another evidence for the role of
prolidase in the regulation of NF-κB expression provides an
experiment showing that inhibition of prolidase activity by
Cbz-Pro contributed to upregulation of NF-κB expression in
fibroblasts (Surazynski et al. 2008a). In fact, our data
showed that the HYD-dependent increase in collagen bio-
synthesis is accompanied by a decrease in the expression of
NF-κB.
The mechanism of HYD-dependent stimulation of proli-
dase activity may undergo indirectly and may involve IGF-
IR. In patients, HYD is known to upregulate 964 genes.
Some of them produce proteins of MAPK signaling (De la
Cruz-Hernández et al. 2011). However, increase in the ex-
pression of IGF-IR was independent of FAK and MAP
kinase (ERK1 and ERK2) expression. Therefore, we suggest
that the HYD-dependent increase of collagen biosynthesis
in cultured human skin fibroblasts results from the activa-
tion of IGF-IR expression and prolidase activity and down-
regulation of NF-κB p65.
Conclusion
The data suggest that HYD may exert its effect on collagen
biosynthesis through stimulation of prolidase activity,
expressions of IGF-IR, HIF-1α, and inhibition of NF-κB
p65.
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